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Despite their close genetic relatedness, apes and African and Asian
monkeys (AAMs) differ in their susceptibility to severe bacterial
and viral infections that are important causes of human disease.
Such differences between humans and other primates are thought
to be a result, at least in part, of interspecies differences in
immune response to infection. However, because of the lack of
comparative functional data across species, it remains unclear in
what ways the immune systems of humans and other primates
differ. Here, we report the whole-genome transcriptomic re-
sponses of ape species (human and chimpanzee) and AAMs (rhe-
sus macaque and baboon) to bacterial and viral stimulation. We
find stark differences in the responsiveness of these groups, with
apes mounting a markedly stronger early transcriptional response
to both viral and bacterial stimulation, altering the transcription of
∼40% more genes than AAMs. Additionally, we find that genes
involved in the regulation of inflammatory and interferon re-
sponses show the most divergent early transcriptional responses
across primates and that this divergence is attenuated over time.
Finally, we find that relative to AAMs, apes engage a much less
specific immune response to different classes of pathogens during
the early hours of infection, up-regulating genes typical of anti-
viral and anti-bacterial responses regardless of the nature of the
stimulus. Overall, these findings suggest apes exhibit increased
sensitivity to bacterial and viral immune stimulation, activating a
broader array of defense molecules that may be beneficial for
early pathogen killing at the potential cost of increased energy
expenditure and tissue damage.
pathogen-associated molecular patterns | primate evolution | early immune
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Despite being close evolutionary relatives, humans, chim-panzees, and African and Asian monkeys (AAMs) exhibit
interspecies differences in sensitivity to and manifestation of
certain bacterial and viral pathogens that are major causes of
mortality in humans (e.g., HIV/AIDS, hepatitis C virus, and a
broad range of commensal gram-negative bacteria commonly im-
plicated in sepsis) (1–5). Humans, for example, are highly sensitive
to stimulation by the gram-negative bacterial-cell-wall component
hexa-acylated lipopolysaccharide (LPS), miniscule amounts of
which (2 to 4 μg/kg) can provoke inflammation, malaise, and fever,
and a slightly higher dose, septic shock (15 μg/kg) (1, 6, 7). In
contrast, baboons and macaques require doses nearly 10-fold
higher in concentration to trigger similar symptoms (5, 8, 9).
Pattern recognition receptors (PRRs) such as Toll-like receptors
(TLRs) play a central role in the mediation of innate immune
responses to pathogens (10). The limited number of studies com-
paring leukocyte function after stimulation with TLR-detected
pathogen-associated molecules suggest that the differences in
infectious disease susceptibility noted between apes and AAMs
is, in part, the outcome of lineage-specific evolution of early
innate immune-system regulation and signaling (11–13). Indeed,
innate immune components responsible for detecting pathogens,
including TLRs that sense gram-negative bacteria and single-
stranded RNA viruses, have been found to be under positive
selection in primates (14, 15).
Despite stark differences in the manifestation of severe in-
fections between apes and AAMs, there are few reports directly
comparing the gene-expression response across species to bac-
terial and viral pathogens (11, 12). Furthermore, previous studies
relied mainly on isolated cell types to characterize immune re-
sponses across primates (11, 16), which does not faithfully reflect
the nature of the innate immune response that is a product of the
interaction between several cell populations (17). To better un-
derstand the evolution of the primate immune system, this study
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compares the early responses of apes (humans and common
chimpanzees) and AAMs (rhesus macaques and olive baboons)
to bacterial and viral stimuli. Here, we report on the whole-
genome expression of total blood leukocytes from these four
primate species responding to bacterial and viral stimulation
during the first 24 h of challenge. Our results show that apes and
AAMs have diverged in sensitivity to specific microbial assaults,
such that ape leukocyte responses favor robust antimicrobial
power over pathogen specificity at the potential cost of increased
energetic expenditure and bystander tissue damage.
Results
Evolutionary Relationships Explain Most of the Transcriptional Response
Variation in Primates to Bacteria or Viral Stimulation. To assess
differences in innate immune function between higher-order
primates in as close an approximation to in vivo as possible, we
challenged whole blood from humans (Homo sapiens; n = 6),
common chimpanzees (Pan troglodytes; n = 6), rhesus macaques
(Macaca mulattta; n = 6), and olive baboons (Papio anubis; n = 8)
with bacterial or viral stimuli via venous draw directly into a
media culture tube containing either LPS from Escherichia coli
O111:B4, gardiquimod (GARD), a single-stranded RNA viral
mimetic, or endotoxin-free water, as a negative control (Con-
trol). Both LPS and GARD were chosen as immune stimuli
because they represent microbial components that are millions
to billions of years old, shared across large groups of microor-
ganisms including gram-negative bacterial and single-stranded
RNA (ssRNA) viral pathogens, and are thought to be driving
the evolutionary divergence of primate immune systems. More-
over, there are well-established differences between apes and
AAMs in the manifestation of diseases mediated by such path-
ogens (e.g., immunodeficiency viruses, hepatitis C, and common
commensal bacteria that cause gram-negative bacterial sepsis)
(1, 3, 4). Blood was stimulated for 4 and 24 h before the total
leukocytes were isolated and RNA extracted for RNA-sequencing
(RNA-seq) (Fig. 1A). Following quality control filtering, we ana-
lyzed 151 high-quality RNA-seq profiles across species and
treatment combinations (see Materials and Methods and Dataset
S1). We focus our comparative analyses on the expression levels of
14,140 one-to-one (1:1) orthologous genes, taking into account
potential biases in expression estimates due to differences in
mappability between species (Materials and Methods).
As whole blood contains a variety of leukocyte subtypes, we
first characterized differences in total blood leukocyte compo-
sition between species using fluorescence-activated cell sorting
(FACS). Leukocyte composition differs between species for all
major subtypes measured, with the most notable differences an
increase in the proportion of monocytes in humans (CD14+, P <
0.003) and helper T cells in chimpanzees (CD3+, CD4+; P =
0.0006 to 0.065), relative to other primates (Fig. 1B and Dataset
S2). Using linear models that account for variation in cell com-
position, we next identified genes that respond to LPS and
GARD in each of the species, at each of the time points (see
Materials and Methods). In all species, both treatments led to the
Fig. 1. Characterizing innate immune response upon viral and bacterial stimulation of primate white blood cells. (A) Schematic representation of the study
design. Whole-blood samples from humans, common chimpanzees, rhesus macaques, and olive baboons were stimulated with bacterial or viral stimuli via
venous draw directly into a media culture tube containing either LPS, single-stranded RNA viral mimetic GARD, or endotoxin-free water, as a negative control
(Control). At 4 and 24 h poststimulation, white blood cells were isolated, and RNA was extracted for RNA-seq. (B) Cell proportions of six populations of
leukocytes for all species. Species are indicated on x-axis, and proportions of this population from total leukocytes are on y-axis. PMNs, polymorphonuclear
cells; NK, Natural killer cells. (C) Number of differentially expressed genes (DEGs; FDR < 0.05) in response to LPS (Top) and GARD (Bottom) in each of the
species at 4 and 24 h poststimulation. The exact number of up- and down-regulated genes in each condition in each species are indicated on the bar charts. (D)
Principal component (PC) analysis performed on the log2 fold-change responses observed at 4 h post-LPS and GARD stimulation. PC1 primarily separates apes
(human and chimpanzee) from AAM (macaque and baboon), and PC2 captures differences in immune response to bacterial or viral stimulation.
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up- or down-regulation of hundreds to thousands of genes (false
discovery rate [FDR] < 0.05, Fig. 1C and Dataset S3). As
expected, the transcriptional response to either stimulus was
highly concordant across primates (Spearman’s r range 0.5 to
0.87 across all pairwise comparisons; SI Appendix, Fig. S1), with
stronger correlations between closely related primates than be-
tween more distantly related pairs of species (e.g., at LPS 4 h
Spearman’s r human versus chimpanzee = 0.84, human versus
baboon = 0.50). Consistently, the first principal component (PC)
of the log2 fold-change responses to both LPS and GARD
accounted for ∼20% of the total variance in our dataset and
separated apes (human and chimpanzee) from AAM (macaque
and baboon) (t test; P < 1 × 10−10 for both 4 and 24 h, Fig. 1D).
The second PC captured differences in immune response to
bacterial or viral stimulation (t test; P < 1 × 10−8 for 4 and 24 h;
Fig. 1D). We identified a set of 648 and 257 genes that early after
stimulation (4 h) showed a consistently strong response across all
species to LPS or GARD, respectively (defined as genes with
|log2 FC| > 1 and FDR < 0.05 in all species, Dataset S4). These
genes include most of the key transcription factors involved in
the regulation of innate immune responses to bacterial (e.g.,
NFKB1/2) and viral pathogens (e.g., interferon regulatory factor
[IRF]7/9), as well as several effector molecules involved in the
regulation of inflammatory responses to infection (e.g., IL6,
TNF-α, and IL1-β).
Stronger Early Innate Immune Response in Apes than in AAM. Next,
we sought to characterize differences in immune responses
across species. To do so, we first looked at overall differences in
the magnitude of the transcriptional responses to LPS and GARD
across species (seeMaterials and Methods). We found that, at early
time points, both ape species (human and chimpanzee) engage a
much stronger transcriptional response to both stimuli as com-
pared to rhesus and baboons (on average ∼twofold higher, Wil-
coxon test P < 10−10, Fig. 2A). Next, we identified genes for which
the magnitude of the transcriptional response to LPS or GARD
was significantly different between apes and AAM (FDR < 0.10
for all pairwise contrasts between an ape and an AAM species and
an average |log2 FC| > 0.5). Hereafter, we refer to these genes as
clade differentially responsive genes, or c-DRGs. We identified a
total of 831 and 443 c-DRGs in the early response (4 h) to LPS
and GARD, respectively (Fig. 2B and Dataset S5). Among
c-DRGs, 83 to 92% showed a stronger response in apes as com-
pared to AAM, consistent with the genome-wide pattern of an
overall more robust transcriptional response to immune stimula-
tion in apes. Importantly, the stronger response observed in apes is
not explained by higher baseline expression levels of the receptors
involved in the recognition of LPS (TLR4, CD14, LY96, and
CASP4) and GARD (TLR8) (SI Appendix, Fig. S2). Next, we fo-
cused our analyses on a manually curated list of 1,079 genes be-
longing to different modules of the innate immune system (18)
and that were found to change gene expression in at least one of
our experimental conditions, in at least one of the species from
our dataset. These genes include sensors (n = 188), adaptors (n =
36), signal transducers (n = 209), transcription (factors) (n = 74),
effector (molecules) (n = 115), accessory molecule (n = 54), and
secondary receptors (n = 50). All modules show similar divergence
between clades, with ∼15% of the genes within each module
classified as c-DRGs with a stronger response in apes, as com-
pared to less than 5% showing a significantly stronger response in
AAM (Fig. 2C).
To further characterize functional differences in immune
regulation between apes and AAM, we devised a score of tran-
scriptional divergence at the pathway level. We focused on the
set of 50 “hallmark pathways,” which capture well-defined and
curated biological states or processes (19). Briefly, for each gene
in these pathways, a divergence score between apes and AAM
was computed by calculating the average difference between the
fold-change estimates between all pairs of species of the two
clades, while taking into account variance in transcriptional re-
sponse within each species. The pathway divergence score re-
flects the average divergence scores across all genes of a given
pathway (see Materials and Methods for details). In the early
response to LPS, the most divergent pathways between apes and
AAM were “Interferon alpha response” and “Interferon gamma
response” (P ≤ 0.01, Dataset S6), indicating that the regulation
of interferon responses has significantly diverged since the sep-
aration between apes and AAM. In the early response to GARD,
pathways directly related to the regulation of inflammatory re-
sponses, notably TNF-α signaling, were the most divergent (P ≤
0.01) (Fig. 2D). These results are consistent with recent finding
showing that the transcriptional response of cytokines and che-
mokines to immune stimulation are among the most divergent
across mammals (20). Of note, although many genes are differ-
ently expressed at baseline between apes and AAMs (at an
FDR < 0.01, 871 and 890 at 4 and 24 h in culture, respectively;
Dataset S7), pathways related to interferon responses and in-
flammation are among the least divergent in their baseline gene-
expression levels between the two clades (SI Appendix, Fig. S3).
Moreover, gene ontology (GO) enrichment analysis did not re-
veal any immune-related term that is significantly enriched
among genes differently expressed between apes and AAMs at
baseline (Dataset S8). Thus, we conclude that the differences in
innate immune response identified between apes and AAMs are
unlikely to be explained by baseline differences in the expression
levels of inflammatory markers.
Species-Specific Immune Responses Reflect Unique Immune Regulation
Mechanisms and Lineage-Specific Divergence. Next, we sought to
identify genes that respond to immune stimulation in a species-
specific fashion. These were characterized as genes for which the
magnitude of the response to LPS or GARD in one species was
significantly different to that observed in all other species (see
Materials and Methods). Across time points and immune stimu-
lations, we identified a total of 980, 726, 425, and 655 species-
specific responsive genes in human, chimpanzees, macaques, and
baboons, respectively (Dataset S9). Among baboon-specific re-
sponsive genes, the vast majority (69%) showed a weaker magni-
tude of the response to 4 h of LPS stimulation in baboons as
compared to all other primates (Dataset S9). GO enrichment
analyses (Dataset S10) revealed that these genes were enriched
among defense response genes (FDR = 4.8 × 10−14) and a va-
riety of other GO-associated immune terms (Fig. 3B), including
several key transcription factors (e.g., STAT1 and IRF7/9), major
inflammatory cytokines (e.g., IL1B and CXCL8), and a number
of genes directly involved in LPS sensing and recognition
(adaptor molecules IRAK2, 3, and 4, and the primary LPS re-
ceptor, TLR4) (Fig. 3A and Dataset S9). The weaker response
observed in baboons appears to be, at least in part, due to a
higher baseline expression level of many of these innate immu-
nity genes (SI Appendix, Fig. S4). Baboons have been suggested
to bear higher pathogen loads than apes because of their mating
promiscuity, and so it is tempting to speculate that increased
baseline might represent a mechanism of protection against
frequent microbial infections (21, 22). In rhesus macaques, the
other AAM species, genes showing a stronger response to LPS at
both 4 and 24 h than that observed in all other species (n = 157,
Dataset S9) were mostly enriched among genes involved in the
regulation of inflammatory responses (FDR = 0.002, Dataset
S10), including TREM2 a known suppressor of PI3K and NF-κ-B
signaling in response to LPS.
Among chimpanzee-specific genes, the most notable GO en-
richments were observed among genes showing a weaker response
to LPS at 24 h relative to that observed in all other primates.
These genes were significantly enriched for GO terms associated
with viral defense mechanisms, including “response to virus,” or
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“type I interferon signaling pathway” (FDR < 1 × 10−9, Fig. 3C).
Further inspection of these genes revealed that the vast majority
are strongly up-regulated at 4 h post-LPS stimulation—at similar
levels to those observed in other species—but that chimpanzees
have a unique ability to shutdown these genes at later time points.
For example, the prototypic interferon-responsive gene MX1 is up-
regulated by over fivefold in all primates at 4 h, but by 24 h, MX1
levels have revert to baseline uniquely in chimpanzees (Fig. 3E),
suggesting that chimpanzees are particularly divergent in the regu-
latory circuits associated with the control of viral responsive genes.
In contrast to the pattern observed for baboons, human-
specific responses were associated with genes showing a stronger
response to immune stimulation as compared to that observed in
other primates. GO analyses revealed that these genes are over-
represented among terms related to the regulation of cytokine
production involved in immune response (FDR = 0.045) and T-cell
activation involved in immune response (FDR = 0.06) (Dataset
S10). Notable examples of human-specific responding genes include
the canonical T-cell costimulatory molecule CD80 (average fivefold
increase in response to both stimuli relative to other species) and
IFN-γ, a cytokine central for protective immunity against a large
number of infectious agents and the key determinant of the po-
larization of T cells toward a proinflammatory Th1 phenotype (23)
(Fig. 3D). The higher production of IFN-γ and CD80 in humans
may mediate more effective killing of viral and bacterial pathogens.
Furthermore, as these molecules are important regulators of cyto-
kine production and T-cell activation, it also suggests significantly
different regulation of T-cell responses (24, 25).
Regulatory Divergence Decreases as Infection Proceeds. Next, we
compared the transcriptional divergence between early (4 h) and
late (24 h) immune responses. We observed a marked reduction
in divergence scores at 24 h poststimulation of most hallmark
pathways in the response to both LPS (P = 8 × 10−6) and GARD
(P = 6 × 10−9) (Fig. 4A). In LPS-stimulated cells, the most
striking differences were observed for interferon-related path-
ways, which show a reduction in divergence score of ∼sixfold
between the two time points. In GARD-stimulated cells, the
largest reduction in divergence scores was observed among
pathways related to the regulation of inflammatory responses
(Fig. 4A). These findings indicate that most transcriptional di-
vergence in immune responses among primates occurs during the
initial response to pathogens followed by an overall convergence
to similar response levels at a later time point, specifically among
genes involved in the regulation of inflammation and viral-
associated interferon responses (Fig. 4B). In apes (but not in
AAMs), genes involved in the regulation of inflammation are
strongly enriched among those for which the response to GARD
significantly decreases at the later time point, whereas those
decreasing in response to LPS are enriched for viral response
genes (Fig. 4C and Dataset S11).
Apes Engage a Less-Specific Innate Immune Response than AAM. An
aspect of innate immunity central to its success during microbial
assault is its ability to recognize pathogens and initiate the most
appropriate defense against them by type. The specificity of the
innate immune response to infection is mediated by PRRs that
detect the presence of danger signals via conserved molecular
patterns associated with subtypes of pathogens and host damage
(e.g., penta- and hexa-acylated LPS from gram-negative bacteria
detected by TLR4-LY96 receptors) (26, 27). Signals of viral danger
such as GARD are expected to activate a response mainly controlled
by transcription factors prominent in antiviral defense such as Inter-
feron Regulatory Factors (IRFs), which limit viral replication and
Fig. 2. Stronger early innate immune response in apes than monkeys. (A) For each combination of stimulus and time point, we show the distribution of the
log2 fold changes (x-axis) among genes that respond to that treatment in at least one of the species. The median log2 fold-change responses in each species is
represented by a dashed line. (B) Number of DRGs that are clade- or species-specific differently regulated genes at 4 h post-LPS (Left) and GARD (Right)
stimulation. For c-DRG, we report the number of genes that show a stronger response in a specific clade at the beginning of the ancestral branch of the tree.
For example, in response to LPS, we identified 831 c-DRGs from which 728 show a stronger response in apes and 103 in AAMs. For species-specific responsive
genes, numbers are given in front of each species. The color codes for each species are red for human, cyan for chimp, orange for baboon, and violet for
macaque. (C) Bar plots represent the proportions of different classes of innate immunity genes that are classified as c-DRGs with a higher response in apes
(dark violet) or in AAMs (dark blue). (D) Scatter plot displaying total divergence scores of hallmark pathways for LPS (green) and GARD (pink) at 4 h stim-
ulations. For a given pathway, the total divergence is given by divergence score (DS) on the x-axis and −log10 P values for each DS is on the y-axis. The
pathways names, DS values, and corresponding P values are shown in Dataset S6. We highlight the pathways showing the most significant divergence scores
for both the response to LPS and GARD.
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dissemination through the up-regulation of interferons and
interferon-regulated genes (28, 29). By contrast, recognition of
gram-negative bacteria via cell-wall component LPS stimulates a
broader array of cytokine responses that tends toward expression
of proinflammatory cytokines regulated by transcription factors
NF-κB and AP1 but can also include interferon expression reg-
ulated by transcription factors such as IRF3 and JAK-STAT (28,
30–32)
Two major lines of evidence indicate that early transcriptional
immune responses are less specific in apes than in AAM. First,
we found the transcriptional responses to LPS and GARD were
more similar to each other in apes (humans r = 0.87, chimpan-
zees r = 0.83) than they were in baboons (r = 0.44) or macaques
(r = 0.65) (Fig. 5A). Accordingly, we found about three times
more genes that respond uniquely to either LPS or GARD
(i.e., “ligand specific” genes) in AAM as compared to apes (χ2
test; P = 2.2 × 10−16) (Fig. 5B, see Materials and Methods for
details on the statistical model used to characterize ligand-specific
and shared genes). The second piece of evidence comes from the
nature of the genes that are differentially activated in response to
LPS and GARD. The fact that apes show a higher correlation in
GARD and LPS responses compared to AAMs predicts that they
will tend to activate both antibacterial and antiviral defense
mechanisms regardless of the nature of the stimuli. Supporting
this notion, the genes that exhibited a stronger response in apes
than in AAMs after stimulation with the viral mimetic GARD for
4 h were most significantly enriched genes involved in the regu-
lation of inflammatory responses (P = 7.1 × 10−6; FDR = 0.008,
Dataset S10), whereas genes involved in the response to viruses
(GO term “response to virus”) were enriched upon bacterial LPS
stimulation (P = 0.0023; FDR = 0.15, Dataset S10).
To explore these differences in more detail, we focused on
genes involved in the interferon alpha pathway (viral-associated
response) or inflammatory response (bacterial-associated re-
sponse). In AAMs, inflammatory response genes tended to be
more strongly up-regulated in response to LPS compared to
GARD (P ≤ 0.0027), suggesting that their transcription is partic-
ularly sensitive to receipt of a bacterial danger signal compared to
a viral one. No significant differences in up-regulation of these
same genes were noted between LPS and GARD cells in apes
(Fig. 5C). For example, the canonical proinflammatory cytokine
TNF, which in macaques and baboons is strongly up-regulated
only in response to LPS, is potently up-regulated in response to
both stimuli in humans and chimpanzees (by over ∼fourfold,
Fig. 3. Species-specific immune response reflects unique immune regulation mechanisms and lineage-specific divergence. (A) Circos plots showing different
classes of innate immune genes (clustered using different color codes) classified as species-specific responsive at 4 h post-LPS stimulation in humans (Left) and
baboons (Right). The log2FC key represent the average difference between species response versus all other species in which the positive (red color) and
negative (blue) values indicate the magnitude of the stronger and weaker absolute response in this species versus all others, respectively. (B) GO enrichment
analysis for genes showing a weaker response to LPS at 4 h in baboons as compared to all other species. (C) GO enrichment analysis for genes showing a
weaker response to LPS at 24 h in chimpanzees as compared to all other species. For B and C only, top GO terms are presented. The full list of significant GO
terms can be found in Dataset S10. (D) Boxplot represents the log2FC of IFN-γ and CD80 genes which, at 4 h post-LPS stimulation, were found to have a
significantly stronger response in human than in other primates. (E) Estimates of the mean fold-changes response forMX1 (± SE) at the two time points across
the four primate species studied.
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Fig. 5D). Other examples of this pattern include the classical proin-
flammatory cytokines IL1A and IL1B (SI Appendix, Fig. S5). Like-
wise, interferon-associated genes were more strongly up-regulated in
response to GARD compared to LPS in AAM (P < = 7.7 × 10−6),
while in apes these genes showed more concordant levels of up-
regulation between stimuli (Fig. 5C). Interferon-induced and potent
antiviral genes, including MX1 and OAS1, were much more strongly
up-regulated in response to GARD than to LPS in AAMs compared
to apes (SI Appendix, Fig. S5).
Discussion
Our study provides a genome-wide functional comparison of
variation in innate immune responses between species belonging
to two closely related clades of primates. Ape (human and chim-
panzee) total blood leukocytes were significantly more responsive to
bacterial and viral stimulation compared to total blood leukocytes
obtained from AAM (rhesus macaques and baboons) during the
early hours of challenge, mounting generally stronger and less-
specific transcriptional responses. This increased response suggests
apes maintain increased sensitivity to particular types of micro-
bial assaults compared to AAM, a phenomenon likely to come
with considerable energetic cost (1, 5). From an evolutionary stand-
point, investment in increased sensitivity to pathogens can limit the
negative effects of pathogen exposure on reproductive fitness. Hu-
mans and chimpanzees participate in a comparatively slower life
history than rhesus macaque and olive baboon monkeys—they live
decades longer, take longer to reach sexual maturity, nurture their
young longer, and maintain a larger body size (33–35). A long life at a
large size increases risk of pathogen exposure, both in terms of
number of exposures and absolute load, over the course of a life that
will have long periods of time between the birth of offspring. A slow
life history strategy can be concomitant with an increased risk in
pathogen-mediated limitations to reproductive success, making a
more substantial investment in robust early pathogen detection and
elimination evolutionarily beneficial, compared to the ordinary met-
abolic costs of launching those responses (36, 37).
However, serious bystander tissue damage is a cost for im-
mune protection during severe infections. Pathogen virulence
Fig. 4. Divergence of immune response is reduced at later time point. (A) Scatter plots of divergence scores of hallmark pathways at early (x-axis) and later
time points (y-axis) for LPS (green) and GARD (maroon) stimulations. The inset boxplots contrast the distribution of divergence scores among all pathways
between the two time points. P values were obtained using Mann–Whitney U test. (B) Estimates of the mean response at the two time points for each species
(± SE) across genes bellowing to the interferon alpha and inflammatory response hallmark pathways. (C) GO enrichment analysis for genes that showed
significant decrease in response in apes only (FDR < 0.05 in apes and FDR > 0.05 in monkeys) for LPS and GARD. Top significant GO terms are given as in-
dicated by −log10 P value on the x-axis.
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may play a significant role in the evolution of high-energy low-
specificity early immune responses. The primate genera in this
study substantially differ in their evolutionary exposure to par-
ticular pathogens (e.g., dengue virus, immunodeficiency viruses,
and Zika virus) (38–41). Exposure to pathogens of high virulence
may lead to a low cost–benefit ratio for primate hosts, since the
reproductive and evolutionary benefit of a transiently demanding
immune response outweighs its energetic and tissue costs (42,
43). Under this rubric, a robust but less-specific early response to
pathogens is effective and beneficial most of the time. Any
contribution that response might make to immunopathology in
apes through potentially increased risk of sepsis or chronic in-
flammatory disease is evolutionarily negligible compared to the
persistent risk of infection. Interestingly, among the most divergently
responding pathways between apes and AAMs, several were
associated with the regulation of interferon responses and re-
sponses to viruses. These findings are consistent with a growing
body of literature that pathogens and, specifically, viruses have
been important drivers of adaptive evolution in humans and
other mammals (15, 44–46).
Regardless of initial strength and divergence of transcriptional
response to LPS and GARD, we show that the transcriptional
activity of antiviral (interferon) and inflammatory pathways be-
came attenuated over time and more similar between species.
While acute-phase and early proinflammatory responses are typ-
ically countered by a later anti-inflammatory response to lessen
host damage and maintain homeostasis, the dampening of this
initial, powerful antimicrobial response here is profound over time
Fig. 5. Apes engage a less-specific innate immune response than AAMs. (A) Correlation plots of the magnitude of the fold-change responses between LPS
(x-axis) and GARD-stimulated cells (y-axis). For each of the species, we only include genes that were differentially expressed (FDR < 0.05) in response to at least
one of the stimuli (N = 7,862, 7,874, 6,585, and 5,430 genes for human, chimp, baboon, and macaque, respectively). High correlation was found in apes
(∼0.85), while modest correlation was found in baboon (0.44) and moderate in macaque (0.65). (B) Proportion of ligand-specific (i.e., genes that respond
uniquely to either bacterial or viral stimuli) and shared genes (i.e., genes equally activated by both immune stimuli) across species. (C) Violin plots comparing
(scaled) log2 fold-change responses to 4 h of LPS and GARD stimulation between genes belonging the hallmark pathways “Interferon (IFN) alpha” and
“inflammatory response.” The P values shown have been Bonferroni corrected for the number of tests performed. NS, nonsignificant (i.e., P > 0.05). (D)
Boxplots of the log2 fold-change response (y-axis) of TNF in response to LPS and GARD stimulations across primates.
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(47). Remarkably, in apes the pathways that underwent the most
pronounced attenuation after 24 h tended to be ones not
expected to be strongly engaged in the response to the pathogen
type in the experiment. For instance, the typically antiviral type-I
IFN pathway response was found to be markedly reduced in apes
after 24 h of bacterial but not viral stimulation. While the initial
response of apes to immune stimulus is very strong, temporal
regulation of responding pathways may reduce the energetic
costs of such an immune strategy. What gene regulatory and
immunological mechanisms are involved in such temporal reg-
ulation will require further investigation.
In conclusion, we show initial antibacterial and antiviral re-
sponses of apes to be highly correlated and strongly responsive
when compared to close relatives AAMs. Apes appear to have
adopted an immune strategy that emphasizes sterilization over
specificity, strongly transcribing a greater number of genes in
response to immune stimulation and releasing very similar im-
mune transcriptomic “arsenals” regardless of pathogen type. This
powerful response dramatically shifts during the opening hours of
infection, to involve significantly fewer genes after 24 h, which
may help limit bystander tissue damage. The energetically costly
approach apes initiate in response to immune stimulation may be
favored by this primate family’s adoption of slower life history
with increased risk of pathogen exposure over reproductive life
span or past pathogen exposure. The addition of more primate
species, combined with the use of single-cell RNA sequencing
methods, are important next steps to study the evolution of the
immune system and more precisely map the immune cell types
that contribute the most to divergence in immune response
across primates.
Materials and Methods
Sample Collection and Blood Stimulation. We measured innate immune re-
sponses on a panel of six humans, six chimpanzees, six rhesus macaques, and
eight olive baboons (three females and three males for each species and four
females and four males for baboon). Human samples were obtained via
informed consent. This study was approved by the Research Ethics Board at
the Centre Hospitalier Universitaire Sainte-Justine (Research Ethics Board
approved protocol no. 3557). Nonhuman primate blood samples were hu-
manely collected in accordance with the animal-subject regulatory standards
of the Texas Biomedical Research Institute and Emory University Institutional
Animal Care and Use Committees. These sample locations were chosen to
help control for possible differences in genome expression stemming from
care/management that was primate-center specific versus evolved differ-
ences in gene expression across the different primate lineages. Two more-
distantly related monkey and ape species (rhesus macaque and chimpan-
zees) that were housed and under similar care at Yerkes National Regional
Primate Center (Emory University) were sampled at that location, while their
closest relatives (baboons for macaques and chimpanzees for humans) lived
and were sampled at two different locations: the Texas Biomedical Research
Institute and Montreal, Quebec. Chimpanzee samples were collected prior to
the NIH ban on chimpanzee research.
All human and nonhuman primate subjects were broadly agematched and
healthy. All individuals sampled were young adults to middle-aged adults,
with all human subject between 22 to 55 y of age and all chimps 18 to 23 y of
age. Baboons and macaques were between 7 to14 y of age, which corre-
sponds to 28 to 55 human years, with the exception of two macaques of 3
and 20 y of age (∼12 and ∼80 human years) (48). The responses and dif-
ferential cell counts of these individuals, however, were in keeping with
other macaques. Subjects were screened to ensure they had no chronic ill-
nesses/infections or history of cancer, free of anti-inflammatory medication,
and reported or appeared [in the case of nonhuman primates (NHP)] healthy
on the day of sampling. All rhesus macaques were specific-pathogen free
(herpes B virus, simian immunodeficiency virus, simian betaretrovirus, and
simian T-Cell lymphotrophic virus-1); chimpanzees were free of HIV and
simian immunodeficiency virus, hepatitis B virus, and hepatitis C virus at the
time of sampling. The individuals in this study had as similar a disease and
health experience/status as is possible to know and control (Dataset S1
provides information on the sex, age, and other features of our samples).
We drew 1 mL of whole blood from each animal directly into a TruCulture
tube (Myriad RBM) that contained the following: 1) cell culture media only
(“control”), 2) cell culture media plus 1 μg/mL ultra-pure LPS from the E. coli
0111:B4 strain (“LPS”), or 3) cell culture media plus 1 μg/mL GARD. Samples
were incubated for 4 and 24 h at 37 °C. Following incubation, we separated
the plasma and cellular fractions by centrifugation and lysed and discarded
the red cells from the remaining cell pellet by applying red blood cell lysis
buffer (RBC lysis solution, 5 Prime Inc.) for 10 min followed by centrifugation
and washing with 1× PBS. The remaining white blood cells were lysed in
Qiazol and frozen at −80 °C until library construction (Qiagen). To control
for variation in cellular composition in downstream analyses, we used flow
cytometry to quantify the proportions of leukocyte subtypes, accounting for
polymorphonuclear (CD14dim/SSC-A > 100K/FSC-A > 100K/CD66+), classical
monocytes (CD14+/CD16−), CD14+ intermediate monocytes (CD14+/CD16+),
CD14-nonclassical monocytes (CD14−/CD16+), helper T cells (CD3+/CD4+),
cytotoxic T cells (CD3+/CD8+), double positive T cells (CD3+/CD4+/CD8+),
CD8− B cells (CD3−/CD20+/CD8−), CD8+ B cells (CD3−/CD20+/CD8+), natural
killer T lymphocytes (CD3+/CD16+), and natural killer cells (for monkeys:
CD3−/CD16+ in the lymphocyte scatter; for apes: CD3−/CD16+/CD56+ in the
lymphocyte scatter). Samples for FACS were simultaneously cleared of red
blood cells via lysis and fixed by application of BD FACS-lyse for 2 min, prior
to washing with 1× PBS, and staining with fluorochrome conjugated
monoclonal antibodies (Dataset S12), before washing with 1× PBS and sus-
pending in a 1× PBS and paraformadelhyde solution for analysis on the BD
LSRFortessa platforms. Proportional analysis was completed in FlowJo X,
using BD FACSBeads individually stained with the antibodies to calculate
compensation.
RNA-Seq Data Generation.
Library construction. Total RNA was isolated from cell lysate by phenol::-
chloroform extraction and spin column (miRNAeasy kit, Qiagen), quantified
by spectrophotometry, and assessed for quality using the Agilent 2100
bioanalyzer (Agilent Technologies). Samples with no evidence of RNA deg-
radation (Integrity number >8) were then used for RNA library development.
Messenger RNA was isolated by magnetic bead and converted into RNA li-
braries using the Illumina TruSeq RNA Library preparation kit version 2
according to the manufacturer’s instructions (Illumina). Libraries were se-
quenced on a HiSEq. 2100, producing 151 transcriptomes, at 25 to 30 million
reads per sample. The RNAseq data were deposited in the Gene Expression
Omnibus database under accession no. GSE155918 (49).
Reads Mapping on 1:1 Orthologs. Following sequencing, we trimmed Illumina
adapter sequence from the ends of the reads and removed bases with quality
scores <20 using Trim Galore (version 0.2.7). We used the software Spliced
Transcripts Alignment to a Reference (STAR) to align the reads to an
orthologous reference genome for all four species (50). We developed this
genome using the XSAnno pipeline which combines whole-genome align-
ment, local alignment, and multiple filters to remove regions with differ-
ence in mappability between species (51). XSAnno pipeline identifies
orthologous genes across two species using three major filters, namely,
LiftOver to carry annotation of one species over the other, BLAT aligner to
compare orthologous exons identity between the two species, and simNGS
to identify exons that have different lengths between the species. We used
the genome assemblies of hg19 for human, CHIMP2.1.4 for chimpanzee,
MMUL 1.0 for macaque, and PapAnu2.0 for olive baboon species. We used
human annotation as a reference. The pairwise alignment chains between
human and each species were obtained from University of California, Santa
Cruz genome browser (52). We used different thresholds to define orthol-
ogous regions between the two genomes to carry annotation from one
species to another using AnnoConvert program that utilized LiftOver
according to simulations using liftOverBlockSim PERL script from XSAnno
pipeline (53). The values were 0.98, 0.92, and 0.91 for chimp, baboon, and
macaque, respectively, that were used to assign -minMatch argument in
AnnoConvert. The second step is using reciprocal whole-genome alignment
using BLAT through BlatFilter software of the pipeline using annotations
files generated previously (54). This step will filter exons that are highly di-
vergent between the two species. The last filter is using simNGS to simulate
reads for exons assuming they are not differentially expressed. Then, dif-
ferential expression analysis is performed, and if exons are found to be
differentially expressed, these will be filtered out as it reflects differential
length of the exons between species.
Gene-expression estimates were obtained by summing the number of
reads that mapped uniquely to each species-annotated genome using
HTSeq-count (version 0.6.1) (55). After excluding samples that did not pro-
duce sequenceable libraries and postsequencing quality control, we ana-
lyzed read counts for 151 samples (Humans: 12 controls, 12 LPS, and 12
GARD; Chimpanzee: 12 controls, 12 LPS, and 12 GARD; Rhesus: 11 controls,
12 LPS, and 11 GARD; Baboons: 16 controls, 14 LPS, and 15 GARD; Dataset
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S1). We confirmed the identity of all samples based on genotype informa-
tion derived from single nucleotide polymorphism calls made from the RNA-
seq reads.
Read Normalization and Filtering Lowly Expressed Genes. Prior to RNA-seq
data analysis, we first filtered out genes that were very lowly or not
detectably expressed in our samples. Specifically, we only kept genes whose
expression was higher or equal to one count per million (CPM) in all the
individuals from at least one species and one of the experimental conditions.
This procedure yielded a total of 12,441 genes used for further analysis.
Normalization for sequencing depth and library sizes was done using the
trimmed mean of M-values method (56). We normalized the resulting read-
count matrix using the function voom from the R-package limma to allow
using linear models by limma package (57). The voom algorithm models
mean-variance trend of logCPM for each gene and uses it to compute the
variance as a weight of logCPM values. We then modeled the normalized
expression values as a function of the different experimental factors in the
study design such as species, ligand, and time points.
Statistical Analysis. All statistical analysis was done on R version 3.6.2. Dif-
ferential expression analysis was done using limma package version 3.34.9
(58). We employed linear regression to identify differentially expressed
genes according to different questions asked by designing different models.
We designated a model to test for differences of gene expression across
species and treatments, ∼covariates + species + species:Time.point.stimulant.
The arm Time.point.stimulant is the sample for each experimental condition,
that is, LPS.4 h, LPS.24 h, GARD.4 h, and GARD.24 h. From this design, one
can retrieve ligand responses in each species right away, while responses to
ligands at 24 h are built from linear combinations, such as LPS.24 h to
NC.24 h and GARD.24 h to NC.24 h. To take into account the paired structure
of the data, with different samples coming from the same individuals, we
used the duplicateCorrelation function. The used covariates are the different
cell proportions collected by the FACS data. The cell proportions covariates
are aimed to correct for the different proportion of white blood cells in
different primate species since we conducted the transcriptomic character-
ization on all immune white blood cells. Genes with different magnitudes of
response between clades, referred to as c-DRGs, were characterized. We
established two filters to characterize significant c-DRGs in each treatment.
First, we required the genes not to be differentially responsive to the
treatment, even marginally, between within-clade species pairs (chimp ver-
sus human and baboon versus Macaque, showing FDR > 0.25). Second, we
required that any pairwise comparison involving species from different
clades to be significant at FDR < 0.1. Third, we also computed the average
differences in responses between apes and AAMs. The absolute difference
between the average response in apes versus AAMs is as follows:
logFC.human + logFC. chimp
2
− logFC.macaque + logFC.baboon
2
.
And that contrast was required to be significant at FDR < 0.1, with genes
featuring
|logFC.human + logFC. chimp|
2
− |logFC.macaque + logFC.baboon|
2
  >  0.5
being labeled ape specific and AAM specific for those for which
|logFC.human + logFC. chimp|
2
− |logFC.macaque + logFC.baboon|
2
  <  (−0.5).
Species-specific DRGs were identified using pairwise comparisons at FDR <
0.01, consistent direction of expression in all contrasts, and systematic dif-
ferences corresponding to stronger or weaker responses in the species of
interest with respect to the any of the other three. Finally, we also required
genes to show a logFC in response to the stimulus whose absolute differs in
more than one log2FC with respect to the average of the other three ani-
mals. For humans, as an example, this means the following:
⃒
⃒




Ligand-specific genes in each species are genes that respond to one ligand
(FDR < 0.05) but not to the other (FDR > 0.25), and whose responses to both
ligands are in turn significantly different (FDR < 0.05). Shared genes are
those whose responses to ligands are both significant (FDR < 0.05 in
both) and, at the same time, not significantly different between them
(FDR > 0.25).
Correction of multiple testing was done using FDR, as described by
Benjamini-Hochberg (59).
Divergence Scores. For each time point and stimulus, species were compared
pairwise to retrieve the absolute differences between species’ responses to
the stimulus under analysis. For the pair chimp versus human, for example,
we can define the following:
δhuman.chimp = |logFC.human − logFC. chimp|.
Comparing these differences for pairs of animals within versus across clades,
we obtained divergence scores as follows:
DS = δhuman.macaque + δhuman.baboon + δchimp.macaque + δchimp.baboon
4
− δhuman.chimp + δmacaque.baboon
2
.
The analysis was conducted for all 50 hallmark pathways. We restrict the
analysis in a given pathway to responsive genes (FDR < 0.05 in any species),
whose average DS is reported. A P value for each DS of a given pathway was
calculated by contrasting the DSs of genes of this specific pathway against
the DSs of all responsive genes using Wilcoxon test.
We note that the fact that a given pathway is strongly responsive to
immune activation does not necessarily translate into an elevated divergence
score. The divergence score reflects how different (i.e., divergent) is the
magnitude of the response between apes andAAMs, relative to differences in
response within apes and AAMs. Thus, we could have a pathway that is
strongly up- or down-regulated in response to immune stimulation and yet
have a low divergence score. This could happen if 1) apes and AAMs respond
to the stimulation with a similar magnitude, or 2) if the within-clade vari-
ance is larger than the between-clade variance in response.
Functional Characterization. We conducted the functional characterization
using GO enrichment implemented in the CluGO application (2.5.5) of
Cytoscape (version 3.7.2) (60). The Benjamini-Hochberg method for multiple
correction was used, and all orthologous genes, 12,441 genes, were used as a
background. Default values were used for the rest of the parameters. FDR
cutoff use was below 0.15.
Data Availability. The RNA-seq data generated in this study have been de-
posited in Gene Expression Omnibus (accession no. GSE155918) (49).
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